Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet

American Journal of Pathology

Volumn 179, Issue 5, 2011, Pages 2278-2289

  Kassel, Karen M ^a   Owens III, A Phillip ^b   Rockwell, Cheryl E ^a   Sullivan, Bradley P ^a   Wang, Ruipeng ^a   Tawfik, Ossama ^a   Li, Guodong ^a   Guo, Grace L ^a   MacKman, Nigel ^b   Luyendyk, James P ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; FIBRIN; HEMATOPOIETIC CELL DERIVED TISSUE FACTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBOPLASTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; HEPATITIS; LIPID LIVER LEVEL; MALE; MOLECULAR PATHOLOGY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN DIET;

ANIMALS; BLOOD COAGULATION; BONE MARROW TRANSPLANTATION; DIET; FATTY LIVER; HEMATOPOIETIC STEM CELLS; HEPATITIS; LIPOGENESIS; MICE; MICE, INBRED C57BL; RECEPTOR, PAR-1; RNA, MESSENGER; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 80054972257     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.07.015     Document Type: Article

References (70)

1. C.Z. Larter, S. Chitturi, D. Heydet, and G.C. Farrell A fresh look at NASH pathogenesis, part 1: the metabolic movers J Gastroenterol Hepatol 25 2010 672 690
2. J.M. Clark, F.L. Brancati, and A.M. Diehl Nonalcoholic fatty liver disease Gastroenterology 122 2002 1649 1657
3. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 2006 S99 S112
4. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 2008 1655 1669
5. A. Kotronen, and H. Yki-Jarvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38
6. C.P. Day, and O.F. James Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463 1466
7. J.B. Schwimmer, P.E. Pardee, J.E. Lavine, A.K. Blumkin, and S. Cook Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease Circulation 118 2008 277 283
8. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
9. G. Targher, M. Chonchol, L. Miele, G. Zoppini, I. Pichiri, and M. Muggeo Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome Semin Thromb Hemost 35 2009 277 287
10. M. Cigolini, G. Targher, G. Agostino, M. Tonoli, M. Muggeo, and G. De Sandre Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men: role of the metabolic syndrome Thromb Haemost 76 1996 69 73
11. C.E. Ndumele, K. Nasir, R.D. Conceicao, J.A. Carvalho, R.S. Blumenthal, and R.D. Santos Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation Arterioscler Thromb Vasc Biol 31 2011 1927 1932
12. G. Targher, L. Bertolini, F. Poli, S. Rodella, L. Scala, R. Tessari, L. Zenari, and G. Falezza Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 54 2005 3541 3546
13. S.S. Choi, and A.M. Diehl Hepatic triglyceride synthesis and nonalcoholic fatty liver disease Curr Opin Lipidol 19 2008 295 300
14. D.G. Tiniakos, M.B. Vos, and E.M. Brunt Nonalcoholic fatty liver disease: pathology and pathogenesis Annu Rev Pathol 5 2010 145 171
15. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings, L.D. Ferrell, Y.C. Liu, M.S. Torbenson, A. Unalp-Arida, M. Yeh, A.J. McCullough, and A.J. Sanyal Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
16. R. Stienstra, F. Saudale, C. Duval, S. Keshtkar, J.E. Groener, N. van Rooijen, B. Staels, S. Kersten, and M. Muller Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity Hepatology 51 2010 511 522
17. W. Huang, A. Metlakunta, N. Dedousis, P. Zhang, I. Sipula, J.J. Dube, D.K. Scott, and R.M. O'Doherty Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance Diabetes 59 2010 347 357
18. Y. Tamura, M. Sugimoto, T. Murayama, M. Minami, Y. Nishikaze, H. Ariyasu, T. Akamizu, T. Kita, M. Yokode, and H. Arai C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice J Atheroscler Thromb 17 2010 219 228
19. A. Rull, F. Rodriguez, G. Aragones, J. Marsillach, R. Beltran, C. Alonso-Villaverde, J. Camps, and J. Joven Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis Cytokine 48 2009 273 279
20. H. Wobser, C. Dorn, T.S. Weiss, T. Amann, C. Bollheimer, R. Buttner, J. Scholmerich, and C. Hellerbrand Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells Cell Res 19 2009 996 1005
21. Y. Tamura, M. Sugimoto, T. Murayama, Y. Ueda, H. Kanamori, K. Ono, H. Ariyasu, T. Akamizu, T. Kita, M. Yokode, and H. Arai Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice Arterioscler Thromb Vasc Biol 28 2008 2195 2201
22. N. Mackman Tissue-specific hemostasis in mice Arterioscler Thromb Vasc Biol 25 2005 2273 2281
23. S.R. Coughlin How the protease thrombin talks to cells Proc Natl Acad Sci U S A 96 1999 11023 11027
24. P. Fritsch, M. Kleber, A. Rosenkranz, M. Fritsch, W. Muntean, H. Mangge, and T. Reinehr Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels Atherosclerosis 212 2010 650 655
25. M. Romano, M.T. Guagnano, G. Pacini, S. Vigneri, A. Falco, M. Marinopiccoli, M.R. Manigrasso, S. Basili, and G. Davi Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women J Clin Endocrinol Metab 88 2003 5321 5326
26. E. Sola, S. Navarro, P. Medina, A. Vaya, A. Estelles, A. Hernandez-Mijares, and F. Espana Activated protein C levels in obesity and weight loss influence Thromb Res 123 2009 697 700
27. L. Ay, H.P. Kopp, J.M. Brix, C. Ay, P. Quehenberger, G.H. Schernthaner, I. Pabinger, and G. Schernthaner Thrombin generation in morbid obesity: significant reduction after weight loss J Thromb Haemost 8 2010 759 765
28. C.W. Kopp, H.P. Kopp, S. Steiner, S. Kriwanek, K. Krzyzanowska, A. Bartok, R. Roka, E. Minar, and G. Schernthaner Weight loss reduces tissue factor in morbidly obese patients Obes Res 11 2003 950 956
29. G. Targher, L. Bertolini, L. Scala, G. Zoppini, L. Zenari, and G. Falezza Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men: role of visceral adipose tissue Diabet Med 22 2005 1354 1358
30. G. de Larranaga, S.P. Wingeyer, M. Graffigna, S. Belli, K. Bendezu, S. Alvarez, O. Levalle, and H. Fainboim Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome Clin Appl Thromb Hemost 14 2008 319 324
31. A. Kotronen, L. Joutsi-Korhonen, K. Sevastianova, R. Bergholm, A. Hakkarainen, K.H. Pietilainen, N. Lundbom, A. Rissanen, R. Lassila, and H. Yki-Jarvinen Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease Liver Int 31 2011 176 183
32. J.P. Luyendyk, B.P. Sullivan, G.L. Guo, and R. Wang Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice Am J Pathol 176 2010 177 186
33. M.E. Rinella, and R.M. Green The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance J Hepatol 40 2004 47 51
34. K.M. Kassel, G.L. Guo, O. Tawfik, and J.P. Luyendyk Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet Lab Invest 90 2010 1794 1804
35. A.J. Connolly, D.Y. Suh, T.K. Hunt, and S.R. Coughlin Mice lacking the thrombin receptor, PAR1, have normal skin wound healing Am J Pathol 151 1997 1199 1204
36. R. Pawlinski, J.G. Wang, A.P. Owens III, J. Williams, S. Antoniak, M. Tencati, T. Luther, J.W. Rowley, E.N. Low, A.S. Weyrich, and N. Mackman Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice Blood 116 2010 806 814
37. G.C. Parry, J.H. Erlich, P. Carmeliet, T. Luther, and N. Mackman Low levels of tissue factor are compatible with development and hemostasis in mice J Clin Invest 101 1998 560 569
38. Y. Tanaka, L.M. Aleksunes, R.L. Yeager, M.A. Gyamfi, N. Esterly, G.L. Guo, and C.D. Klaassen NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet J Pharmacol Exp Ther 325 2008 655 664
39. B.L. Copple, A. Banes, P.E. Ganey, and R.A. Roth Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure Toxicol Sci 65 2002 309 318
40. J. Behari, T.H. Yeh, L. Krauland, W. Otruba, B. Cieply, B. Hauth, U. Apte, T. Wu, R. Evans, and S.P. Monga Liver-specific β-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis Am J Pathol 176 2010 744 753
41. B. Cieply, G. Zeng, T. Proverbs-Singh, D.A. Geller, and S.P. Monga Unique phenotype of hepatocellular cancers with exon-3 mutations in β-catenin gene Hepatology 49 2009 821 831
42. A. Nakagomi, M. Sasaki, Y. Ishikawa, M. Morikawa, T. Shibui, Y. Kusama, H. Atarashi, and K. Mizuno Upregulation of monocyte tissue factor activity is significantly associated with low-grade chronic inflammation and insulin resistance in patients with metabolic syndrome Circ J 74 2010 572 577
43. A.P. Owens, R.E. Temel, D.A. Barcel, S.M. Marshall, A.L. McDaniel, and N. Mackman Hyperlipidemia increases microparticle tissue factor and the activation of coagulation: a tale of mice and monkeys (abstract) Circulation 122 2010 A20151
44. S. Clement, C. Juge-Aubry, A. Sgroi, S. Conzelmann, V. Pazienza, B. Pittet-Cuenod, C.A. Meier, and F. Negro Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes Hepatology 48 2008 799 807
45. M. Endo, T. Masaki, M. Seike, and H. Yoshimatsu TNF-α induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c) Exp Biol Med (Maywood) 232 2007 614 621
46. B.M. De Taeye, T. Novitskaya, O.P. McGuinness, L. Gleaves, M. Medda, J.W. Covington, and D.E. Vaughan Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity Am J Physiol Endocrinol Metab 293 2007 E713 E725
47. M.L. MacDonald, R.R. Singaraja, N. Bissada, P. Ruddle, R. Watts, J.M. Karasinska, W.T. Gibson, C. Fievet, J.E. Vance, B. Staels, and M.R. Hayden Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice J Lipid Res 49 2008 217 229
48. K.R. Coenen, and A.H. Hasty Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice Am J Physiol Endocrinol Metab 293 2007 E492 E499
49. H. Kang, J.K. Greenson, J.T. Omo, C. Chao, D. Peterman, L. Anderson, L. Foess-Wood, M.A. Sherbondy, and H.S. Conjeevaram Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD Am J Gastroenterol 101 2006 2247 2253
50. E. Vanni, E. Bugianesi, A. Kotronen, S. De Minicis, H. Yki-Jarvinen, and G. Svegliati-Baroni From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42 2010 320 330
51. E.P. Newberry, Y. Xie, S.M. Kennedy, J. Luo, and N.O. Davidson Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice Hepatology 44 2006 1191 1205
52. I.J. Hickman, C.M. Sullivan, S. Flight, C. Campbell, D.H. Crawford, P.P. Masci, T.M. O'Moore-Sullivan, J.B. Prins, and G.A. Macdonald Altered clot kinetics in patients with non-alcoholic fatty liver disease Ann Hepatol 8 2009 331 338
53. H.J. Beijers, I. Ferreira, H.M. Spronk, B. Bravenboer, J.M. Dekker, G. Nijpels, C.H. Ten, and C.D. Stehouwer Body composition as determinant of thrombin generation in plasma: the Hoorn study Arterioscler Thromb Vasc Biol 30 2010 2639 2647
54. Q.M. Anstee, and R.D. Goldin Mouse models in non-alcoholic fatty liver disease and steatohepatitis research Int J Exp Pathol 87 2006 1 16
55. A. Dela Pena, I. Leclercq, J. Field, J. George, B. Jones, and G. Farrell NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis Gastroenterology 129 2005 1663 1674
56. M.T. Flowers, and J.M. Ntambi Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism Curr Opin Lipidol 19 2008 248 256
57. M. Miyazaki, M.T. Flowers, H. Sampath, K. Chu, C. Otzelberger, X. Liu, and J.M. Ntambi Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis Cell Metab 6 2007 484 496
58. M.E. Miquilena-Colina, E. Lima-Cabello, S. Sanchez-Campos, M.V. Garcia-Mediavilla, M. Fernandez-Bermejo, T. Lozano-Rodriguez, J. Vargas-Castrillon, X. Buque, B. Ochoa, P. Aspichueta, J. Gonzalez-Gallego, and C. Garcia-Monzon Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C Gut 60 2011 1394 1402
59. D.P. Koonen, R.L. Jacobs, M. Febbraio, M.E. Young, C.L. Soltys, H. Ong, D.E. Vance, and J.R. Dyck Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity Diabetes 56 2007 2863 2871
60. A. Rullier, N. Senant, W. Kisiel, P. Bioulac-Sage, C. Balabaud, B. Le Bail, and J. Rosenbaum Expression of protease-activated receptors and tissue factor in human liver Virchows Arch 448 2006 46 51
61. B.L. Copple, F. Moulin, U.M. Hanumegowda, P.E. Ganey, and R.A. Roth Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide- induced hepatocellular injury in perfused livers J Pharmacol Exp Ther 305 2003 417 425
62. M.D. Gaca, X. Zhou, and R.C. Benyon Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors J Hepatol 36 2002 362 369
63. S. Fiorucci, E. Antonelli, E. Distrutti, B. Severino, R. Fiorentina, M. Baldoni, G. Caliendo, V. Santagada, A. Morelli, and G. Cirino PAR1 antagonism protects against experimental liver fibrosis: role of proteinase receptors in stellate cell activation Hepatology 39 2004 365 375
64. N. Mackman Regulation of tissue factor gene expression in human monocytic and endothelial cells Haemostasis 26 Suppl 1 1996 17 19
65. M. Saliola, R. Lorenzet, D. Ferro, S. Basili, C. Caroselli, A.D. Santo, M. Sallese, and F. Violi Enhanced expression of monocyte tissue factor in patients with liver cirrhosis Gut 43 1998 428 432
66. M. Arai, S. Mochida, A. Ohno, I. Ogata, H. Obama, I. Maruyama, and K. Fujiwara Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor Thromb Res 80 1995 113 123
67. S. Mochida, M. Arai, A. Ohno, F. Yamanobe, K. Ishikawa, A. Matsui, I. Maruyama, H. Kato, and K. Fujiwara Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats Hepatology 29 1999 1532 1540
68. Y. Kobayashi, N. Yoshimura, K. Nakamura, H. Yamagishi, and T. Oka Expression of tissue factor in hepatic ischemic-reperfusion injury of the rat Transplantation 66 1998 708 716
69. M. Guha, M.A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S.F. Yan, D. Stern, and N. Mackman Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression Blood 98 2001 1429 1439
70. E. Emekli-Alturfan, I. Basar, A.A. Alturfan, F. Ayan, L. Koldas, H. Balci, and N. Emekli The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes Pathophysiol Haemost Thromb 36 2007 290 297